Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Elettaria cardamomum Distillate Increases Cellular Immunity in Doxorubicin Treated Rats

Indonesian Journal of Cancer Chemoprevention · Vol. 3 No. 3 (2012) · hlm. 437–443

DOI
10.14499/indonesianjcanchemoprev3iss3pp437-443
ISSN
2355-8989, 2088-0197
Terbit
2012-10-31
Penerbit
Indonesian Society for Cancer Chemoprevention
Bahasa
eng

Abstrak

Doxorubicin is one of chemotherapeutic agent used for cancer therapy. However, doxorubicin usage causes some adverse effects, such as lymphocyte, CD4+ and CD8+ cells number. Therefore, the co-chemotherapeutic agent is required to reduce the imunosuppression effect. Cardamom (Elettaria cardamomum) contains terpenoid 1,8 cineol. This research aimed to know the effect of Elettaria cardamomum distillate (ECD) in combination with doxorubicin on Sprague Dawley rat’s hematology profile and the amount of CD4+ and CD8+ cells. The experiment was done for 13 days using 6 groups of rats: I doxorubicin (dox) 15 mg/kg BW; II dox + ECD5 mg/kg BW; III dox + ECD 50 mg/kg BW; IV dox + ECD 100 mg/kg BW; V ECD 100 mg/kg BW; VI control without treatment. The hematology profile and the amount of CD4+ and CD8+ were counted before and after treatment using flowcytometer. The results show that ECD increases the amount of lymphocyte, white blood, CD4+ and CD8+ cells in dose dependent manner in doxorubicin treated rats. Based on the data, it can be concluded that ECD is potential to be developed as immunostimulant agent for chemotherapy.Keywords: Cardamom (Elettaria cardamomum), immunostimulant, hematology, CD4+, CD8+

Jaringan kolaborasi para penulis

34 penulis · 139 tautan kepenulisan bersama · 42 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Gadjah Mada
  • Universitas Medika Suherman
  • Universitas Muhammadiyah Banten
  • Universidade de Díli
  • Kementerian Kesehatan Republik Indonesia
  • National Research and Innovation Agency
  • Universitas Jember
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Riris Istighfari JenieUniversitas Gadjah Mada5
Rohmad Yudi UtomoUniversitas Gadjah Mada2
Prisnu TirtanirmalaUniversitas Gadjah Mada2
Edy MeiyantoUniversitas Gadjah Mada2
Rohani SiregarUniversitas Medika Suherman1
La Ode Akbar RasydyUniversitas Muhammadiyah Banten1
La Ode Muhammad AnwarUniversitas Medika Suherman1
Tri Wahyuni IsmoyowatiUniversitas Medika Suherman1
Salma Hilmy Rusydi HashimUniversitas Medika Suherman1
Emmelia Kristina HutagaolUniversitas Medika Suherman1
Cicilia Nony Ayuningsih BratajayaUniversitas Medika Suherman1
Aprilina SartikaUniversitas Medika Suherman1
Dandi SanjayaUniversitas Medika Suherman1
Hajar Nur Fathur RohmahUniversitas Medika Suherman1
Joao Manuel Correia XimenesUniversidade de Díli1
Argandita MeiftasariUniversitas Gadjah Mada1
Januar Caesar W.P.Universitas Gadjah Mada1
J. W.Universitas Gadjah Mada1
Sari HaryantiKementerian Kesehatan Republik Indonesia1
Dhania NovitasariUniversitas Gadjah Mada1
Herwandhani PutriUniversitas Gadjah Mada1
Beni LestariUniversitas Gadjah Mada1
Ria Fajarwati KastianNational Research and Innovation Agency1
Amalia MirandaUniversitas Gadjah Mada1
Imroatus SholihahUniversitas Gadjah Mada1
Refki RiswansyahUniversitas Gadjah Mada1
Hilyatul FadliyahUniversitas Gadjah Mada1
Ika Rahmawati SutejoUniversitas Jember1
Raisatun Nisa SugiyantoUniversitas Gadjah Mada1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ijcc.chemoprev.org/index.php/ijcc/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Elettaria cardamomum Distillate Increases Cellular Immunity in Doxorubicin Treated Rats</dc:title>
	<dc:creator>Raksamiharja, Rikat</dc:creator>
	<dc:creator>Sy, Khairunnisa</dc:creator>
	<dc:creator>S., Meirizky Zulharini</dc:creator>
	<dc:creator>Novarina, Annisa</dc:creator>
	<dc:creator>Sasmito, Ediati</dc:creator>
	<dc:description xml:lang="en-US">Doxorubicin is one of chemotherapeutic agent used for cancer therapy. However, doxorubicin usage causes some adverse effects, such as lymphocyte, CD4+ and CD8+ cells number. Therefore, the co-chemotherapeutic agent is required to reduce the imunosuppression effect. Cardamom (Elettaria cardamomum) contains terpenoid 1,8 cineol. This research aimed to know the effect of Elettaria cardamomum distillate (ECD) in combination with doxorubicin on Sprague Dawley rat’s hematology profile and the amount of CD4+ and CD8+ cells. The experiment was done for 13 days using 6 groups of rats: I doxorubicin (dox) 15 mg/kg BW; II dox + ECD5 mg/kg BW; III dox + ECD 50 mg/kg BW; IV dox + ECD 100 mg/kg BW; V ECD 100 mg/kg BW; VI control without treatment. The hematology profile and the amount of CD4+ and CD8+ were counted before and after treatment using flowcytometer. The results show that ECD increases the amount of lymphocyte, white blood, CD4+ and CD8+ cells in dose dependent manner in doxorubicin treated rats. Based on the data, it can be concluded that ECD is potential to be developed as immunostimulant agent for chemotherapy.Keywords: Cardamom (Elettaria cardamomum), immunostimulant, hematology, CD4+, CD8+</dc:description>
	<dc:publisher xml:lang="en-US">Indonesian Society for Cancer Chemoprevention</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2012-10-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijcc.chemoprev.org/index.php/ijcc/article/view/68</dc:identifier>
	<dc:identifier>10.14499/indonesianjcanchemoprev3iss3pp437-443</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Cancer Chemoprevention; Vol 3, No 3 (2012); 437-443</dc:source>
	<dc:source>2355-8989</dc:source>
	<dc:source>2088-0197</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijcc.chemoprev.org/index.php/ijcc/article/view/68/68</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Indonesian Journal of Cancer Chemoprevention</dc:rights>
</oai_dc:dc>